Clinical Trial Update: Orexin Receptor Antagonists as Modulators of Threat Sensitivity in Individuals With Alcohol Use Disorder [EARLY_Phase 1]

View source ↗

Summary

An early Phase 1 trial evaluated orexin receptor antagonists as modulators of threat sensitivity in individuals with Alcohol Use Disorder. Results were posted o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder

Snippet

Sponsor: Ohio State University | Conditions: Alcohol Use Disorder | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2025-10-30